Itamar Shalit
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria
Papers in
-
- Antibiotic Resistance in Bacteria 10
- Co-authors
- A. DalhoffA GoreaRoberto BessalleIna FabianMati FridkinDrora HalperinNir OsherovItzhak Levy
- Journals
- Antimicrobial Agents and Chemotherapy (14 papers)Journal of Antimicrobial Chemotherapy (7 papers)Drugs (3 papers)European Journal of Clinical Microbiology & Infectious Diseases (3 papers)Clinical Infectious Diseases (2 papers)
- Partner nations
- IsraelUnited StatesGermany
In The Last Decade
Itamar Shalit
81 papers receiving 3.2k citations
Peers
Comparison fields: 5 of 133
- Applied Microbiology and Biotechnology 242
- Molecular Medicine 529
- Microbiology 541
- Infectious Diseases 867
- Clinical Biochemistry 219
Countries citing papers authored by Itamar Shalit
This map shows the geographic impact of Itamar Shalit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Itamar Shalit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Itamar Shalit more than expected).
Fields of papers citing papers by Itamar Shalit
This network shows the impact of papers produced by Itamar Shalit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Itamar Shalit. The network helps show where Itamar Shalit may publish in the future.
Co-authors
The 25 scholars most cited alongside Itamar Shalit, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 4 | |
| 2 | 2012 | 19 | |
| 3 | 2011 | 21 | |
| 4 | 2010 | 56 | |
| 5 | 2009 | 19 | |
| 6 | 2009 | 16 | |
| 7 | 2007 | 22 | |
| 8 | 2006 | 36 | |
| 9 | 2005 | 31 | |
| 10 | 2005 | 57 | |
| 11 | 2004 | 50 | |
| 12 | Cefuroxime efficacy in pneumonia: sequential short-course i.v./oral suspension therapy. | 1994 | 21 |
| 13 | 1994 | 28 | |
| 14 | 1993 | 3 | |
| 15 | 1993 | 73 | |
| 16 | 1992 | 27 | |
| 17 | 1990 | 253 | |
| 18 | 1990 | 49 | |
| 19 | 1986 | 14 | |
| 20 | 1985 | 20 |
About Itamar Shalit
Itamar Shalit is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology, Microbiology, Pharmacology and Infectious Diseases, having authored 82 papers that have together received 3.4k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (20 papers), Antifungal resistance and susceptibility (14 papers), Antibiotic Resistance in Bacteria (10 papers), Antimicrobial Resistance in Staphylococcus (9 papers), Cancer therapeutics and mechanisms (9 papers), Antimicrobial Peptides and Activities (6 papers), Hematopoietic Stem Cell Transplantation (6 papers) and Pneumonia and Respiratory Infections (6 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (242 citations), Molecular Medicine (529 citations), Microbiology (541 citations), Infectious Diseases (867 citations) and Clinical Biochemistry (219 citations). Itamar Shalit has collaborated with scholars based in Israel, United States and Germany. Frequent co-authors include A. Dalhoff, A Gorea, Roberto Bessalle, Ina Fabian, Mati Fridkin, Drora Halperin, Nir Osherov, Itzhak Levy, Yona Shadkchan and Melvin I. Marks. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Journal of Antimicrobial Chemotherapy, Drugs, European Journal of Clinical Microbiology & Infectious Diseases and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.